Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Read article at bloomberg.com
Saturday, 9 August 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment